MQ710
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MQ710, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer [Phase 1]